• Careers
  • Investors
  • News
    • Press Releases
    • Recent Media
    • Scientific Publications
  • Who We Are
    • About Nanoscope
    • Leadership
    • Management Team
    • Board of Directors
    • Visionary Advisory Committee
  • The Science
  • Our Future
    • Pipeline
    • Disease Targets
    • Clinical Trials for RP
    • Clinical Trials for Stargardt
  • For Patients
    • Hear from Patients
    • Patient & Caregiver Resources
  • Contact

Recent Posts

  • Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
  • Nanoscope Therapeutics President and Chief Scientific Officer Dr. Samarendra Mohanty to Be Featured Speaker at 2025 ISPE Annual Meeting and Expo
  • Nanoscope Therapeutics Announces Durable 3-Year Vision Improvements from REMAIN Study of MCO-010 in Retinitis Pigmentosa
  • PIE Magazine | Practical Paths to Vision Restoration, Turning Bipolar Cells into Light Catchers – Dr. Samarendra Mohanty and Dr. Stephen Tsang Talk
  • Opthalmology Times | Video Interview: AAO 2025: Kenneth C. Fan, MD, sees vision gains with MCO-010 in Stargardt Disease

Recent Comments

    Archives

    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • May 2023
    • April 2023
    • March 2023
    • January 2023
    • October 2022
    • September 2022
    • July 2022
    • May 2022
    • February 2022
    • January 2022
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • October 2020
    • July 2020
    • June 2020
    • September 2018
    • October 2017

    Categories

    • Home Page
    • Nanoscope in the News
    • Nanoscope Press Release
    • Presentations
    • Publications

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    June 3, 2021 in Nanoscope in the News

    Opthalmology Times: Optogenetic gene therapy restores vision in 11 RP patients

    Nanoscope Therapeutics 0 Like Post Comments Off on Opthalmology Times: Optogenetic gene therapy restores vision in 11 RP patients
    Read More
    June 3, 2021 in Nanoscope in the News

    Ocular Surgery News: Optogenetics, goggles increase visual perception in case of inherited retinal dystrophy

    Nanoscope Therapeutics 0 Like Post Comments Off on Ocular Surgery News: Optogenetics, goggles increase visual perception in case of inherited retinal dystrophy
    Read More
    May 19, 2021 in Home Page, Nanoscope in the News

    Nature Gene Therapy: Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice

    Nanoscope Therapeutics 0 Like Post Comments Off on Nature Gene Therapy: Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice
    Read More
    March 6, 2021 in Home Page, Nanoscope in the News

    14 Emerging Tech Trends for 2021—and Dallas-Area Companies That Are Innovating for the Future

    Nanoscope Therapeutics 0 Like Post Comments Off on 14 Emerging Tech Trends for 2021—and Dallas-Area Companies That Are Innovating for the Future
    Read More
    February 9, 2021 in Home Page, Nanoscope in the News

    Nature: Light-activated genetic therapy to treat blindness enters clinic

    Nanoscope Therapeutics 0 Like Post Comments Off on Nature: Light-activated genetic therapy to treat blindness enters clinic
    Read More
    October 22, 2020 in Nanoscope in the News

    Injection that could improve fading sight in aging eyes starts human trials after curing blindness in mice

    Nanoscope Therapeutics 0 Like Post Comments Off on Injection that could improve fading sight in aging eyes starts human trials after curing blindness in mice
    Read More
    October 22, 2020 in Nanoscope in the News

    Human trials for genetic jab that lets blind mice see again

    Nanoscope Therapeutics 0 Like Post Comments Off on Human trials for genetic jab that lets blind mice see again
    Read More
    July 21, 2020 in Nanoscope in the News

    Nanoscope Therapeutics Closes Series A, Names Alvaro Guillem as Chairman

    Nanoscope Therapeutics 0 Like Post Comments Off on Nanoscope Therapeutics Closes Series A, Names Alvaro Guillem as Chairman
    Read More
    June 1, 2020 in Nanoscope in the News

    Two TechFW Clients Receive Awards from NASA and the National Eye Institute

    Nanoscope Therapeutics 0 Like Post Comments Off on Two TechFW Clients Receive Awards from NASA and the National Eye Institute
    Read More
    September 24, 2018 in Nanoscope in the News

    Dallas Morning News: Bedford biomedical firm wins major backing for tech that could restore damaged retinas

    Nanoscope Therapeutics 0 Like Post Comments Off on Dallas Morning News: Bedford biomedical firm wins major backing for tech that could restore damaged retinas
    Read More
    Prev1…345Next
    NSCOPE_nu_Logo_Horizontal_white

    FOLLOW US

    Linkedin Instagram Facebook X-twitter

    Contact Us
    Terms of Use
    Expanded Access Policy

    ©2021-2025 Nanoscope Therapeutics, Inc.

    This website uses cookies to improve your experience. By clicking "Accept", you consent to the use of ALL the cookies. However you may visit the Cookie Settings to provide a controlled consent. Cookie settings Accept
    Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled

    This is an necessary category.

    Non Necessary

    This is an non-necessary category.

    Save & Accept